Rita De Sanctis

36PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersData mining and knowledge discoveryModels of care and place of birthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 31, 2026
Switching CDK4/6 inhibitors to overcome toxicity in HR-positive/HER2-negative advanced breast cancer.

|Jun 25, 2026
Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials.

|Dec 15, 2025
From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching.

Mariangela Gaudio, Anna Floreani, Greta Schivardi

|Dec 01, 2025
[18F]FDG PET/CT as a biomarker for response evaluation in neoadjuvant treatment of early breast cancer: could it become a game-changer in the scenario of the emerging (de)-escalation strategies?

Riccardo Gerosa, Fabrizia Gelardi, Paola Tiberio

|Nov 06, 2025
Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast Cancer.

Elena Zazzetti, Saverio D'Amico, Flavia Jacobs

|Jul 12, 2025
Using [18F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer-Results from a Prospective Patient Cohort.

Fabrizia Gelardi, Paola Tiberio, Rosalba Torrisi

Pageof 6

Frequent Collaborators

16 joint publications

Alberto Zambelli

16 joint publications

Armando Santoro

13 joint publications

Flavia Jacobs

12 joint publications

Paola Tiberio